These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35066335)
1. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway. Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335 [TBL] [Abstract][Full Text] [Related]
3. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells. Zhao YL; Yuan BQ; Shen GS Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330 [TBL] [Abstract][Full Text] [Related]
5. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling. Zhu J; Li X; Zhang S; Liu J; Yao X; Zhao Q; Kou B; Han P; Wang X; Bai Y; Zheng Z; Xu C Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S87-S95. PubMed ID: 34219514 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway. Chen J; Zeng C; Jin J; Zhang P; Zhang Y; Zhang H; Li Y; Guan H Endocrine; 2024 Jul; 85(1):238-249. PubMed ID: 38191984 [TBL] [Abstract][Full Text] [Related]
7. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway. Yang M; Huang S; Zhao Y; Xie B; Hu X; Cai Y Biochem Biophys Res Commun; 2023 May; 655():104-109. PubMed ID: 36934585 [TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of TRIB2 by Wnt/β-catenin activation in BRAF Wang N; Wen J; Ren W; Wu Y; Deng C Cancer Chemother Pharmacol; 2021 Jul; 88(1):155-164. PubMed ID: 33860836 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway. Zhou Z; Liu Y; Ma M; Chang L Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy. Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469 [TBL] [Abstract][Full Text] [Related]
13. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway. Wu Y; Chen W; Zhang B; Liu H Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180 [TBL] [Abstract][Full Text] [Related]
14. ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells. Zhan F; Zhang R; Qiu L; Ren Y Int J Biochem Cell Biol; 2024 Sep; 174():106635. PubMed ID: 39098591 [TBL] [Abstract][Full Text] [Related]
15. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling. Geng Q; Deng H; Fu J; Cui F Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034 [TBL] [Abstract][Full Text] [Related]
16. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway. Lv P; Xue Y Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460 [TBL] [Abstract][Full Text] [Related]
17. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway. Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805 [TBL] [Abstract][Full Text] [Related]
18. CXCR4 promotes migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway. Hu Y; Xu Z; Zhou D; Hou H; Liu B; Long H; Hu W; Tang Y; Wang J; Wei D; Zhao Q J Cancer Res Ther; 2024 Aug; 20(4):1241-1250. PubMed ID: 39206986 [TBL] [Abstract][Full Text] [Related]
19. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537 [TBL] [Abstract][Full Text] [Related]
20. CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway. Cai X; Lv Y; Pan J; Cao Z; Zhang J; Li Y; Zheng H Curr Protein Pept Sci; 2024; 25(5):386-393. PubMed ID: 38265409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]